INFORCE 3 is the first and only respiratory vaccine that prevents respiratory disease cause by BRSV, while also aiding in the prevention of IBR and PI3, to help get cattle off to a healthier, more productive start.
Efficacy
- In Zoetis efficacy studies, all calves vaccinated with INFORCE 3 survived a severe BRSV challenge in which all unvaccinated controls died.1,2
- The studies also demonstrated that those calves vaccinated with INFORCE 3 showed fewer lung lesions and reduced viral shedding.
- Additionally, INFORCE 3 was shown to help prevent respiratory disease caused by IBR and PI3, and reduce IBR and PI3 viral shedding.3,4,5
Safety
As demonstrated in three separate safety studies, INFORCE 3 is safe for use in all types, ages and classes of cattle. INFORCE 3 was demonstrated safe for use in very young, high-stress calves, weaned and high-stress stocker calves, and pregnant heifers and cows.
Key benefits and features
- Developed specifically for intranasal use
- Helps prime the immune system for a memory response to subsequent vaccinations as well as disease challenges
- Contains proprietary, temperature-sensitive IBR and PI3 strains that replicate most effectively in the upper respiratory tract
- Includes a high-titer formulation of a low-passaged strain of BRSV
- Helps deliver a healthy start for young dairy and beef calves
- For dairy herds, INFORCE 3 can be used in baby calves, on arrival, at weaning, before moving to group pens, or with cows and heifers prefreshening
- INFORCE 3 is perfect for use in beef herds in calves at branding, preconditioning, weaning, pre-shipment, or on arrival in stocker or feedlots.
1 Data on file, Study Report No. 3131R-60-08-557, Zoetis Inc.
2 Data on file, Study Report No. 3131R-60-09-669, Zoetis Inc.
3 Data on file, Study Report No. 3131R-60-08-548, Zoetis Inc.
4 Data on file, Study Report No. 3131R-60-09-720, Zoetis Inc.
5 Data on file, Study Report No. 3131R-60-08-568, Zoetis Inc.
